Inception Return
(7/15/1996)
|
5.92 %
|
|
YTD Return
|
-1.96 %
|
|
NAVPS
(5/14/2026)
|
$21.74
|
|
Change
|
($0.08) / -0.38 %
|
|
|
Growth of $10,000
(As of April 30, 2026)
|
|
MER
|
2.95 %
|
|
Assets ($mil)
|
$276.75
|
|
Rank (1Yr)
|
211/283
|
|
Std Dev (3Yr)
|
17.96 %
|
|
Volatility Ranking (3Yr)
|
9/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Partially Open
|
|
|
Objective
The Fund aims to provide long-term capital growth by investing primarily in mid-sized U.S. corporations.
|
Fund Manager
I.G. Investment Management, Ltd.
Portfolio Manager
I.G. Investment Management, Ltd.
Sub-Advisor
Philip Taller, Mackenzie Financial Corporation
John Lumbers, Mackenzie Financial Corporation
Arup Datta, Mackenzie Financial Corporation
Nicholas Tham, Mackenzie Financial Corporation
Denis Surorov, Mackenzie Financial Corporation
Haijie Chen, Mackenzie Financial Corporation
|
|
Asset Allocation
(As of February 28, 2026)
|
Sector Allocation
(As of February 28, 2026)
|
Geographic Allocation
(As of February 28, 2026)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| United States Dollars | Cash and Equivalents | Cash and Cash Equivalent | United States | 4.79% |
| Neogen Corp | US Equity | Healthcare | United States | 4.57% |
| Cirrus Logic Inc | US Equity | Technology | United States | 3.95% |
| Align Technology Inc | US Equity | Healthcare | United States | 3.86% |
| Maximus Inc | US Equity | Industrial Services | United States | 3.72% |
| Parsons Corp | US Equity | Technology | United States | 3.65% |
| Akamai Technologies Inc | US Equity | Technology | United States | 3.50% |
| Bio-Techne Corp | US Equity | Healthcare | United States | 3.43% |
| Charles River Laboratories Intl Inc | US Equity | Healthcare | United States | 3.41% |
| Verra Mobility Corp Cl A | US Equity | Technology | United States | 3.35% |
Performance Data
(As of April 30, 2026)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
2.71
|
-2.90
|
-4.53
|
-1.96
|
10.02
|
2.61
|
-1.30
|
4.20
|
|
Benchmark
|
5.98
|
6.92
|
9.79
|
8.77
|
31.06
|
17.03
|
9.32
|
11.81
|
|
Quartile Ranking
|
4
|
4
|
4
|
4
|
3
|
4
|
4
|
4
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
-4.06
|
9.34
|
5.71
|
-18.50
|
17.43
|
8.06
|
19.68
|
-8.06
|
2.49
|
12.62
|
|
Benchmark
|
7.19
|
24.39
|
13.76
|
-11.77
|
20.00
|
11.78
|
21.65
|
-2.87
|
8.66
|
14.08
|
|
Quartile Ranking
|
4
|
3
|
4
|
3
|
4
|
3
|
3
|
4
|
4
|
2
|